Clinical Trials Logo

Stroke clinical trials

View clinical trials related to Stroke.

Filter by:

NCT ID: NCT05321446 Not yet recruiting - Stroke Clinical Trials

GoHand(TM) to Enhance Recovery of Arm and Hand Function Post-Stroke

GoHand
Start date: July 1, 2022
Phase: N/A
Study type: Interventional

This is a proof-of-concept study aimed at contributing evidence towards the need, usability and efficacy potential of the GoHandTM sensor in people with reduced hand function post-stroke. A two group, randomized, proof-of-concept, trial. The outcome is change over a one-month period in movement quality as measured by the GoHand sensor. The intervention period is one month. The intervention to be tested is the GoHand sensor, specifically the auditory feedback provided for an optimal wrist and hand movement during everyday tasks. To standardize the practice sessions, all persons will be taught the GRASP (Graded Repetitive Arm Supplementary Program) which has been shown to be of benefit to people recovering from stroke. The intervention group will practice the GRASP program with the sensor in feedback mode and the control group will practice with the sensor without feedback. The total sample size is 12, 6 per group. The study will be used to create movement metric algorithms and provide preliminary data for extent of change and usability.

NCT ID: NCT05310630 Not yet recruiting - Clinical trials for Acute Ischemic Stroke

Study to Evaluate The Safety and Efficacy of Balovaptan in Patients With Acute Ischemic Stroke at High Risk of Developing Malignant Brain Edema

Start date: March 31, 2022
Phase: Phase 2
Study type: Interventional

This study is designed to evaluate the safety, efficacy, and pharmacokinetics of balovaptan compared with placebo in participants with acute ischemic stroke (AIS) at risk of developing malignant cerebral edema (MCE)

NCT ID: NCT05305625 Not yet recruiting - Stroke Clinical Trials

Effect of Remote Ischemic Postcondioning on Glymphatic System in Acute Stroke

Start date: May 1, 2022
Phase: N/A
Study type: Interventional

Investigators aimed to investigate the changes of glymphatic function after remote ischemic postcondioning treatment in acute ischemic stroke .

NCT ID: NCT05293080 Not yet recruiting - Atrial Fibrillation Clinical Trials

Early Treatment of Atrial Fibrillation for Stroke Prevention Trial in Acute STROKE

EAST-STROKE
Start date: September 2024
Phase: Phase 3
Study type: Interventional

This study will determine whether early, comprehensive, rhythm control therapy prevents adverse cardiovascular outcome in patients with acute ischemic stroke and atrial fibrillation compared to usual care.

NCT ID: NCT05289518 Not yet recruiting - Clinical trials for Acute Ischemic Stroke

Remote Ischemic Conditioning for the Treatment of Stroke-related Insomnia

RIC-SI
Start date: April 1, 2022
Phase: N/A
Study type: Interventional

This study intends to further reveal the effect of RIC in stroke-related insomnia and explore its potential mechanisms.

NCT ID: NCT05288270 Not yet recruiting - Stroke Clinical Trials

ROBOtic Care of Post-stroke Pain.

Robocop
Start date: April 1, 2022
Phase: N/A
Study type: Interventional

In agreement to the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) recommendations that support the importance of physical functioning as core outcome for pain this randomized, double-blind, controlled clinical trial will be the pilot forming the rational basis for the assessment of the efficacy in the use of Robotic rehabilitation system to prevent chronic post stroke pain development. In fact, according to working hypothesis, proprioceptive inputs with high-intensive bilateral movement training of the hemiplegic arm can improve recovery and plasticity, thus preventing chronic post-stroke pain from occurring within the 3-6 months following stroke.

NCT ID: NCT05277311 Not yet recruiting - Ischemic Stroke Clinical Trials

Efficacy and Safety of LongShengZhi Capsule on Functional Recovery After Acute Ischaemic Stroke (LONGAN)

Start date: May 1, 2022
Phase: N/A
Study type: Interventional

The aim of the study is to determine if LongShengZhi Capsule is effective and safe in patients with ischemic stroke in comparison to placebo. This trial is a prospective, multicenter, randomized, placebo-controlled, double-blinded, parallel-group, superiority trial.

NCT ID: NCT05270122 Not yet recruiting - Ischemic Stroke Clinical Trials

ThrombX Retriever for Acute Ischemic Stroke Trial

TRAC
Start date: May 2022
Phase: N/A
Study type: Interventional

This trial is designed to assess the safety and effectiveness of the ThrombX Retriever.

NCT ID: NCT05268861 Not yet recruiting - Clinical trials for Cognitive Impairment

The Role of Cognition in Motor Learning After Stroke

Start date: April 2022
Phase: N/A
Study type: Interventional

Stroke leads to lasting problems in using the upper limb (UL) for everyday life activities. While rehabilitation programs depend on motor learning, UL recovery is less than ideal. Implicit learning is thought to lead to better outcomes than explicit learning. Cognitive factors (e.g., memory, attention, perception), essential to implicit motor learning, are often impaired in people with stroke. The objective of this study is to investigate the role of cognitive deficits on implicit motor learning in people with stroke. The investigators hypothesize that 1) subjects with stroke will achieve better motor learning when training with additional intrinsic feedback compared to those who train without additional intrinsic feedback, and 2) individuals with stroke who have cognitive deficits will have impairments in their ability to use feedback to learn a motor skill compared to individuals with stroke who do not have cognitive deficits. A recent feedback modality, called error augmentation (EA), can be used to enhance motor learning by providing subjects with magnified motor errors that the nervous system can use to adapt performance. The investigators will use a custom-made training program that includes EA feedback in a virtual reality (VR) environment in which the range of the UL movement is related to the patient's specific deficit in the production of active elbow extension. An avatar depiction of the arm will include a 15 deg elbow flexion error to encourage subjects to increase elbow extension beyond the current limitations. Thus, the subject will receive feedback that the elbow has extended less than it actually has and will compensate by extending the elbow further. Subjects will train for 30 minutes with the EA program 3 times a week for 9 weeks. Kinematic and clinical measures will be recorded before, after 3 weeks, after 6 weeks, and after 9 weeks. Four weeks after the end of training, there will be a follow-up evaluation. Imaging scans will be done to determine lesion size and extent, and descending tract integrity with diffusion tensor imaging (DTI). This study will identify if subjects with cognitive deficits benefit from individualized training programs using enhanced intrinsic feedback. The development of treatments based on mechanisms of motor learning can move rehabilitation therapy in a promising direction by allowing therapists to design more effective interventions for people with problems using their upper limb following a stroke.

NCT ID: NCT05258500 Not yet recruiting - Stroke Clinical Trials

Strength Training in Hospitalized Patients Using the Ghostly App: a Feasibility Study

Start date: July 2022
Phase: N/A
Study type: Interventional

The goal of this feasibility study is to evaluate the use of the Ghostly app in rehabilitation of stroke patients, elderly and patients recovering from COVID-19 or ICU patients. In three randomized controlled trials, the effect of a strength training program incorporated in the Ghostly app will be assessed for 1) stroke patients suffering from weakness of the lower limb, 2) frail elderly with gait difficulties and 3) patients recovering from COVID-19 or ICU patients who suffer from muscle weakness. Additionally, the effect of BFR on strength gain in all these three populations will be tested.